NCT04220983View on ClinicalTrials.gov

PRAGMA (Prostate Radio Ablation Guided by Magnetic Resonance Imaging Acquisition) in Metastatic Prostate Cancer

NACompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

January 27, 2020

Primary Completion Date

February 28, 2023

Study Completion Date

February 28, 2023

Conditions
Metastatic Prostate Cancer
Interventions
RADIATION

MR-Guided Prostate SBRT

Prostate SBRT has become a standard of care for the treatment of localized prostate cancer. Radiation is delivered to the prostate and seminal vesicles in 5 treatment sessions (fractions). Doses ranging from 35-45 Gy in 5 fractions have demonstrated good outcomes with acceptable toxicity when planning is delivered appropriately.

Trial Locations (1)

10065

Weill Cornell Medicine, New York

All Listed Sponsors
lead

Weill Medical College of Cornell University

OTHER

NCT04220983 - PRAGMA (Prostate Radio Ablation Guided by Magnetic Resonance Imaging Acquisition) in Metastatic Prostate Cancer | Biotech Hunter | Biotech Hunter